These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26467660)

  • 1. Antifungal coatings by caspofungin immobilization onto biomaterials surfaces via a plasma polymer interlayer.
    Griesser SS; Jasieniak M; Coad BR; Griesser HJ
    Biointerphases; 2015 Dec; 10(4):04A307. PubMed ID: 26467660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin on ARGET-ATRP grafted PHEMA polymers: Enhancement and selectivity of prevention of attachment of Candida albicans.
    Michl TD; Giles C; Mocny P; Futrega K; Doran MR; Klok HA; Griesser HJ; Coad BR
    Biointerphases; 2017 Aug; 12(5):05G602. PubMed ID: 28851227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterials surfaces capable of resisting fungal attachment and biofilm formation.
    Coad BR; Kidd SE; Ellis DH; Griesser HJ
    Biotechnol Adv; 2014; 32(2):296-307. PubMed ID: 24211473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C; Rodier MH; Daniault G; Imbert C
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
    Cateau E; Rodier MH; Imbert C
    J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility to antifungal agents of Candida sp. and biofilm formation].
    Ciok-Pater E; Białucha A; Gospodarek E; Ostafin A
    Med Dosw Mikrobiol; 2011; 63(2):171-87. PubMed ID: 22184912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of caspofungin against planktonic and sessile Candida sp. cells.
    Serefko A; Chudzik B; Malm A
    Pol J Microbiol; 2006; 55(2):133-7. PubMed ID: 17419291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
    Shirazi F; Kontoyiannis DP
    Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms.
    Bink A; Kucharíková S; Neirinck B; Vleugels J; Van Dijck P; Cammue BP; Thevissen K
    J Infect Dis; 2012 Dec; 206(11):1790-7. PubMed ID: 22984120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High salt stability and protein resistance of poly(L-lysine)-g-poly(ethylene glycol) copolymers covalently immobilized via aldehyde plasma polymer interlayers on inorganic and polymeric substrates.
    Blättler TM; Pasche S; Textor M; Griesser HJ
    Langmuir; 2006 Jun; 22(13):5760-9. PubMed ID: 16768506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens.
    Coad BR; Lamont-Friedrich SJ; Gwynne L; Jasieniak M; Griesser SS; Traven A; Peleg AY; Griesser HJ
    J Mater Chem B; 2015 Nov; 3(43):8469-8476. PubMed ID: 32262686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
    DiDone L; Oga D; Krysan DJ
    Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface coatings with covalently attached anidulafungin and micafungin prevent Candida albicans biofilm formation.
    Naderi J; Giles C; Saboohi S; Griesser HJ; Coad BR
    J Antimicrob Chemother; 2019 Feb; 74(2):360-364. PubMed ID: 30376123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
    Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
    Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
    Mazari W; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combatting fungal biofilm formation by diffusive release of fluconazole from heptylamine plasma polymer coating.
    Naderi J; Giles C; Saboohi S; Griesser HJ; Coad BR
    Biointerphases; 2020 Dec; 15(6):061012. PubMed ID: 33339460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.